Abstract
Ventilator associated pneumonia remains a cause of significant morbidity and mortality in Intensive Care patients despite advances in knowledge and technology. The presence of an endotracheal tube bypassing the normal airway barriers, oropharyngeal bacterial colonisation, patient position and repetitive micro-aspiration tip the host-pathogen relationship in favour of the pathogen and promote lung infection in a time-dependent manner. Defending the lung against microbial invasion and infection is a multiplicity of innate and adaptive immune mechanisms, which can identify and eliminate potential pathogens. These defence mechanisms include the ability to recognise pathogens through cell-surface receptors, antimicrobial peptides and proteins, pro and anti-inflammatory mediators and factors related to the coagulant state of the lung fluid. The mechanisms are characterised by their complexity, their remarkable degree of redundancy and effectiveness.
Keywords: Inspired Gases, Klebsiella pneumoniae, phagocytic cells, Cathelicidins, peptide antibiotics, Defensins
Current Respiratory Medicine Reviews
Title: Lung Defence Mechanisms and Their Potential Role in the Prevention of Ventilator Associated Pneumonia
Volume: 2 Issue: 3
Author(s): Matt Wise, Josephine Lightowler and Christopher Garrard
Affiliation:
Keywords: Inspired Gases, Klebsiella pneumoniae, phagocytic cells, Cathelicidins, peptide antibiotics, Defensins
Abstract: Ventilator associated pneumonia remains a cause of significant morbidity and mortality in Intensive Care patients despite advances in knowledge and technology. The presence of an endotracheal tube bypassing the normal airway barriers, oropharyngeal bacterial colonisation, patient position and repetitive micro-aspiration tip the host-pathogen relationship in favour of the pathogen and promote lung infection in a time-dependent manner. Defending the lung against microbial invasion and infection is a multiplicity of innate and adaptive immune mechanisms, which can identify and eliminate potential pathogens. These defence mechanisms include the ability to recognise pathogens through cell-surface receptors, antimicrobial peptides and proteins, pro and anti-inflammatory mediators and factors related to the coagulant state of the lung fluid. The mechanisms are characterised by their complexity, their remarkable degree of redundancy and effectiveness.
Export Options
About this article
Cite this article as:
Wise Matt, Lightowler Josephine and Garrard Christopher, Lung Defence Mechanisms and Their Potential Role in the Prevention of Ventilator Associated Pneumonia, Current Respiratory Medicine Reviews 2006; 2 (3) . https://dx.doi.org/10.2174/157339806778018971
DOI https://dx.doi.org/10.2174/157339806778018971 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of 5-Hydroxymethylcytosine in Aging and Alzheimer’s Disease: Current Status and Prospects for Future Studies
Current Alzheimer Research Thymoquinone Anticancer Discovery: Possible Mechanisms
Current Drug Discovery Technologies May Oxygen-Ozone Therapy Improves Cardiovascular Disorders?
Cardiovascular & Hematological Disorders-Drug Targets The Pharmacogenomics “Side-effect” of TP53/EGFR in Non-small Cell Lung Cancer Accompanied with Atorvastatin Therapy: A Functional Network Analysis
Anti-Cancer Agents in Medicinal Chemistry Impact of Renin-Angiotensin System in Hepatocellular Carcinoma
Current Cancer Drug Targets Recent Advances in Medicinal Chemistry of Sulfonamides. Rational Design as Anti-Tumoral, Anti-Bacterial and Anti-Inflammatory Agents
Mini-Reviews in Medicinal Chemistry Association of EGF rs4444903 and XPD rs13181 Polymorphisms with Cutaneous Melanoma in Caucasians
Medicinal Chemistry Beyond the "Lock and Key" Paradigm: Targeting Lipid Rafts to Induce the Selective Apoptosis of Cancer Cells
Current Medicinal Chemistry Delivery and Application of Dietary Polyphenols to Target Organs, Tissues and Intracellular Organelles
Current Drug Metabolism Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Anti-angiogenic Treatment in Metastatic Colorectal Cancer: Current Issues and Future Aims
Current Cancer Therapy Reviews New Insights into HLA-G and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Editorial: microRNAs: Potential Targets for the Treatment of Cardiovascular Disease
Current Vascular Pharmacology Blocking HIV-1 Vif Restores a Natural Mechanism of Intracellular Antiviral Defense
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Nanomedicines as Cancer Therapeutics: Current Status
Current Cancer Drug Targets Endothelial Cell Targeted Molecular Imaging in Tumor Angiogenesis: Strategies and Current Status
Current Pharmaceutical Biotechnology Somatostatin Receptor-Targeted Anti-Cancer Therapy
Current Drug Delivery Production of Lentivectors for Clinical Use
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Emerging Molecular Functions of MicroRNA-9: Cancer Pathology and Therapeutic Implications
Anti-Cancer Agents in Medicinal Chemistry The Endothelin Axis as Therapeutic Target in Human Malignancies: Present and Future
Current Pharmaceutical Design